title: Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
authors.forename: Stefan V
authors.initials: SV
authors.lastname: Goldberg
authors.forename: Daniel
authors.initials: D
authors.lastname: Hanson
authors.forename: Charles A
authors.initials: CA
authors.lastname: Peloquin
mesh_terms: D000368:Aged; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000494:pharmacology; D001262:Atenolol / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D017828:Rifabutin / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012294:Rifamycins / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000904:Antibiotics, Antitubercular; D000959:Antihypertensive Agents; D012294:Rifamycins; D017828:Rifabutin; D001262:Atenolol; D012293:Rifampin